Open Access. Powered by Scholars. Published by Universities.®
- Keyword
-
- Coronavirus (2)
- Pandemic (2)
- Public health (2)
- Vaccines (2)
- 3D printing (1)
-
- COVAX (1)
- COVID (1)
- COVID Open Pledge (1)
- COVID-19 (1)
- Ebola (1)
- Emergency response (1)
- FDA (1)
- Food and Drug Administration (1)
- For-profit (1)
- Gilead (1)
- Healthcare markets (1)
- Incentives (1)
- Innovation (1)
- Intellectual property (1)
- MERS (1)
- Nationalism (1)
- PPPs (1)
- Patent pools (1)
- Patents (1)
- Pharmaceuticals (1)
- Pledge (1)
- Preparedness (1)
- Private public partnerships (1)
- Procurement (1)
- Rational basis (1)
Articles 1 - 4 of 4
Full-Text Articles in Medicine and Health Sciences
The Intellectual Property Of Covid-19, Ana Santos Rutschman
The Intellectual Property Of Covid-19, Ana Santos Rutschman
All Faculty Scholarship
The response to COVID-19 is indissolubly tied to intellectual property. In an increasingly globalized world in which infectious disease pathogens travel faster and wider than before, the development of vaccines, treatments and other forms of medical technology has become an integral part of public health preparedness and response frameworks. The development of these technologies, and to a certain extent the allocation and distribution of resulting outputs, is informed by intellectual property regimes. These regimes influence the commitment of R&D resources, shape scientific collaborations and, in some cases, may condition the widespread availability of emerging technologies. As seen throughout this chapter, …
The Problem With Relying On Profit-Driven Models To Produce Pandemic Drugs, Ana Santos Rutschman
The Problem With Relying On Profit-Driven Models To Produce Pandemic Drugs, Ana Santos Rutschman
All Faculty Scholarship
The longstanding problems of relying on a market response to a pandemic are becoming readily apparent in the United States, which has quickly become the epicenter of the COVID-19 outbreak. The problems are particularly pronounced in pharmaceutical markets, where we are pinning our hopes for both cures and vaccines. In previous work we have shown how characteristics of healthcare markets in the United States create a divergence between the private incentives of for-profit companies and public health needs, leading to sub-optimal health outcomes in what is a uniquely market-driven healthcare system. In this Essay, written as the COVID-19 pandemic unfolds, …
Reviving Focused Scrutiny In The Constitutional Review Of Public Health Measures, Robert Gatter
Reviving Focused Scrutiny In The Constitutional Review Of Public Health Measures, Robert Gatter
All Faculty Scholarship
This article re-examines the "focused scrutiny" standard proposed by Prof. Scott Burris in 1989 and argues for its application particularly during an infectious disease emergency such as the COVID-19 pandemic. Focused scrutiny seeks to tie judicial review of the constitutionality of public health measures closely to the facts of the particular disease and to evidence of the efficacy of each governmental action to prevent the spread of that disease, even when courts adopt rational basis testing.
Covid-19 And The Conundrum Of Mask Requirements, Robert Gatter, Seema Mohapatra
Covid-19 And The Conundrum Of Mask Requirements, Robert Gatter, Seema Mohapatra
All Faculty Scholarship
As states begin to loosen their COVID-19 restrictions, public debate is underway about what public health measures are appropriate. Many states have some form of mask-wearing orders to prevent the spread of COVID-19 infection. Public health guidance from the Centers for Disease Control and Prevention and the World Health Organization has conflicted. From a public health point of view, it is not clear what the right answer is. In the absence of directives, individuals are also making their own choices about mask use. At a time when public health measures, like shelter-in-place orders and social distancing, are being used to …